Discover how strategic use of animal-origin-free (AOF) peptones can dramatically boost monoclonal antibody (mAb) titers, enhance CHO cell viability, and improve protein quality — all while maintaining process consistency. This white paper reveals how peptone selection and optimization can drive up to 64% higher yields and support robust, scalable biomanufacturing.
In this white paper, you will uncover:
- The importance of peptone selection
- How peptones influence protein quality
- The impact of peptone blends on titer yield
Sponsored by: